Skip to main content
SpringerLink
Log in

Ventricular performance in spontaneously hypertensive rats (SHR) with reduced cardiac mass

  • Hypertension
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

This study was designed to investigate the effect of 4 weeks of captopril treatment on cardiac mass and performance in spontaneously hypertensive rats (SHR). Left (LV) and right (RV) ventricular mass of SHR and normotensive WKY rats was reduced (p<0.01). Mean arterial pressure (MAP) and total peripheral resistance index (TPRI) in the treated SHR and WKY were reduced; cardiac (CI) and stroke (SI) indices remained unaltered in SHR but increased in WKY. Ventricular performance (i.e., cardiac pumping ability), assessed by rapid blood infusion, did not differ between untreated SHR and WKY, and between treated and untreated WKY rats. However, the ventricular performance curves for the treated SHR shifted down and to the right from the untreated SHR (p<0.01). Moreover, when MAP of treated SHR (with regressed LV mass) was elevated to their pretreatment levels, cardiac performance curves shifted further rightward and downward. In contrast, the performance curves of treated WKY whose MAP was also elevated to the level of untreated WKY were no different from those of untreated WKY. These data demonstrate that captopril treatment (at doses used in this study) reduced MAP in SHR through decreased TPRI while decreasing biventricular mass. Furthermore, the cardiac-pumping ability of previously hypertrophied SHR hearts was reduced, suggesting that certain antihypertensive agents that diminish cardiac mass could produce impaired cardiac function when called upon to increase performance (e.g., when MAP is suddenly raised).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Frohlich ED. Haemodynamics of hypertension. In: Genest J, Koiw E, Kuchel O, (editors)Hypertension: Physiopathology and Treatment. New York: McGraw-Hill, 1977:15–49.

    Google Scholar 

  2. Frohlich ED, Tarazi RC. Is arterial pressure the sole factor responsible for hypertensive cardiac hypertrophy?Am J Cardiol 1979;44:959–963.

    PubMed  Google Scholar 

  3. Tarazi RC, Frohlich ED. Is reversal of cardiac hypertrophy a desirable goal of antihypertensive therapy?Circulation 1987;75(I):113–117.

    Google Scholar 

  4. Ishise S, Pegram BL, Frohlich ED. Disparate effects of methyldopa and clonidine on cardiac mass and hemodynamics in rats.Clin Sci 1980;5(Suppl 6):449s-452s.

    Google Scholar 

  5. Kobrin I, Sesoko S, Pegram BL, Frohlich ED. Reduced cardiac mass by nitrendipine is dissociated from systemic or regional hemodynamic changes in rats.Cardiovasc Res 1982; 18:158–162.

    Google Scholar 

  6. Pegram BL, Ishise S, Frohlich ED. Effect of methyldopa, clonidine and hydralazine on cardiac mass and hemodynamics in Wistar-Kyoto and spontaneously hypertensive rats.Cardiovasc Res 1982;16:40–46.

    PubMed  Google Scholar 

  7. Pfeffer JM, Pfeffer MA, Mirsky I, Braunwald E. Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive rat.Proc Natl Acad Sci USA 1982;79:3310–3314.

    PubMed  Google Scholar 

  8. Pfeffer MA, Pfeffer JM, Weiss AK, Frohlich ED. Development of SHR hypertension and cardiac hypertrophy during prolonged beta-blocking therapy.Am J Physiol 1977; 232:H639-H643.

    PubMed  Google Scholar 

  9. Sen S, Tarazi RC, Bumpus FM. Effect of converting enzyme inhibitor (SQ 14225) on myocardial hypertrophy in spontaneously hypertensive rats.Hypertension 1980;2:169–176.

    PubMed  Google Scholar 

  10. Dunn FG, Oigman W, Ventura HO, Messerli FH, Kobrin I, Frohlich ED. Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertension.Am J Cardiol 1984;53:105–108.

    PubMed  Google Scholar 

  11. Amodeo C, Kobrin I, Ventura HO, Messerli FH, Frohlich ED. Immediate ans short-term hemodynamic effects of diltiazem in patients with hypertension.Circulation 1986; 76:108–113.

    Google Scholar 

  12. Schmieder RE, Messerli FH, Nunez BD, Garavaglia GE, Frohlich ED. Isolated septal hypertrophy in early essential hypertension: Hemodynamic, humoral, and volume findings.Circulation 1987;75:1030–1036.

    PubMed  Google Scholar 

  13. Frohlich ED. Hemodynamics and other determinants in development of left ventricular hypertrophy.Fed Proc 1983; 42:2709–2715.

    PubMed  Google Scholar 

  14. Frohlich ED. The first Irvine H. Page lecture: The mosaic of hypertension; past, present, and future.J Hypertension, 1988;6(Suppl. 4):502–511.

    Google Scholar 

  15. Frohlich ED. (State of the Art) The heart in hypertension: Unresolved conceptual challenges.Hypertension 1988;11 (Suppl I):I19-I24.

    PubMed  Google Scholar 

  16. Antonaccio MJ, Rubin B, Horowitz ZP, Laffan RJ, Goldberg ME, High JP, Harris DN, Zaidi I. Effects of chronic treatment with captopril (SQ 14225), an orally active inhibitor of angiotensin I-converting enzyme, in spontaneously hypertensive rats.Jpn J Pharmacol 1979;29:285–294.

    PubMed  Google Scholar 

  17. Giudicelli JG, Freslon JL, Gleason S, Richer D. Captopril and hypertension development in the SHR.Clin Exp Hypertens 1980;2:1083–1096.

    PubMed  Google Scholar 

  18. Koike H, Ito K, Miyamoto M, Nishino H. Effects of longterm blockade of angiotensin converting enzyme with captopril (SQ 14225) on hemodynamic and circulating blood volume in SHR.Hypertension 1980;2:299–303.

    PubMed  Google Scholar 

  19. Sen S, Bumpus FM. Collagen synthesis in development and reversal of cardiac hypertrophy in spontaneously hypertensive rats.Am J Cardiol 1979;44:954–958.

    PubMed  Google Scholar 

  20. Tarazi RC, Fouad FM. Reversal of cardiac hypertrophy in humans.Hypertension 1984; 6 (Suppl III):III140-III146.

    PubMed  Google Scholar 

  21. Pfeffer MA, Pfeffer JM, Frohlich ED. Pumping ability of the hypertrophied left ventricle of the spontaneously hypertensive rat.Circ Res 1976;38:423–429.

    PubMed  Google Scholar 

  22. Spech MM, Ferrario CM, Tarazi RC. Cardiac pumping ability following reversal of hypertrophy and hypertension in spontaneously hypertensive rats.Hypertension 1980;2:75–82.

    PubMed  Google Scholar 

  23. Kuwajima I, Kardon MB, Pegram BL, Sesoko S, Frohlich ED. Regression of left ventricular hypertrophy in two-kidney, one clip Goldblatt hypertension.Hypertension 1982; 4 (Suppl II):II113-II118.

    Google Scholar 

  24. Lundin S, Griberg P, Hallback-Norlander M. Left ventricular hypertrophy improves cardiac performance in spontaneously hypertensive rats.Acta Physiol Scand 1982; 114:321–328.

    PubMed  Google Scholar 

  25. Dunn FG, Chandraratna P, deCarvalho JGR, Basta LL, Frohlich ED. Pathophysiologic assessment of hypertensive heart disease with echocardiography.Am J Cardiol 1977; 39:789–795.

    PubMed  Google Scholar 

  26. Natsume T, Nakajima K, Shibata H, Yokouchi M, Deguchi F, Shimomura K, Ikeda M. Left ventricular and left atrial function in patients with borderline and established hypertension.Jpn Circ J 1983;47:230–239.

    PubMed  Google Scholar 

  27. Strauer BE. Ventricular function and coronary hemodynamics in hypertensive heart disease.Am J Cardiol 1979; 44:999–1006.

    PubMed  Google Scholar 

  28. Sen S, Tarazi RC, Khairallah PA, Bumpus FM. Cardiac hypertrophy and its reversal by antihypertensive drugs in spontaneously hypertensive rats.Clin Exp Pharmacol Physiol 1976;3:173–177.

    PubMed  Google Scholar 

  29. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research.Circ Res 1980; 47:1–9.

    PubMed  Google Scholar 

  30. Braunwald E, Ross J, Sonnenblick EH. Methods for assessing cardiac contractility. In: Braunwald E, Ross J, Sonnenblick EH (eds.)Mechanisms of Contraction of Normal and Failing Heart. Boston: Little Brown, 1967:130–132.

    Google Scholar 

  31. MacGregor D, covell J, Mahler R, Dilley R, Ross J. Relations between afterload, stroke volume and descending limb of Starling curve.Am J Physiol 1974;884–890.

  32. Starksen NF, Simpson PC, Bishopric N, Cough SR, Lee WMF, Escobedo JA, Williams LT. Cardiac myocyte hypertrophy is associated withc-myc proto-oncogene expression.Proc Natl Acad Sci USA 1986;83:8348–8350.

    PubMed  Google Scholar 

  33. Dzau VJ, Gibbons, GH. Autocrine-paracrine mechanisms of vascular myocytes in systemic hypertension.Am J Cardiol 1987;60:99–103.

    PubMed  Google Scholar 

  34. Re RN. Cellular mechanisms of growth in cardiovascular tissue.Am J Cardiol 1987;60:104–109.

    Google Scholar 

  35. Re RN. The myocardial intracellular renin-angiotensin system.Am J Cardiol 1987;59:56–58.

    Google Scholar 

  36. Frohlich ED. Cardiac hypertrophy in hypertension.N Engl J Med 1987;317:831–833.

    PubMed  Google Scholar 

  37. Pfeffers JM, Pfeffer MA, Fletcher P, Fishbein MC, Braunwald E. Favorable effects of therapy on cardiac performance in spontaneously hypertensive rats.Am J Physiol 1982; 242:H776-H784.

    PubMed  Google Scholar 

  38. Ader R, Chatterjee K, Ports T, Brundage B, Hiramatsu B, Parmley W. Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.Circulation 1980; 61:931–937.

    PubMed  Google Scholar 

  39. Davis R, Ribner HS, Keung E, Sonnenblick EH, LeJemtel TH. Effect of captopril in heart failure.N Engl J Med 1979;301:117–121.

    PubMed  Google Scholar 

  40. Gavras H, Faxon DP, Berkoben J, Brunner HR, Ryan TJ. Angiotensin converting enzyme inhibition in patients with congestive heart failure.Circulation 1978;58:77–776.

    PubMed  Google Scholar 

  41. Frohlich ED. Potential mechanisms explaining the risk of left ventricular hypertrophy.Am J Cardiol 1987;59:91A-97A.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Division, Alton Ochsner Medical Foundation, 1516 Jefferson Highway, 70121, New Orleans, Louisiana, USA

    Takashi Natsume, Merrill B. Kardon, Barbara L. Pegram &  Edward D. Frohlich (Vice-President for Academic Affairs)

Authors
  1. Takashi Natsume
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Merrill B. Kardon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Barbara L. Pegram
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Edward D. Frohlich
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Natsume, T., Kardon, M.B., Pegram, B.L. et al. Ventricular performance in spontaneously hypertensive rats (SHR) with reduced cardiac mass. Cardiovasc Drug Ther 3, 433–439 (1989). https://doi.org/10.1007/BF01858115

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01858115

Key Words

Search

Navigation